相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
Clement Bailly et al.
HAEMATOLOGICA (2020)
Correlations Between Imaging Biomarkers and Proliferation Index Ki-67 in Lymphomas: A Systematic Review and Meta-Analysis
Hans-Jonas Meyer et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma
Domenico Albano et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience
Domenico Albano et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Prognostic role of baseline 18F-FDG PET/CT parameters in MALT lymphoma
Domenico Albano et al.
HEMATOLOGICAL ONCOLOGY (2019)
Interest of FDG-PET in the Management of Mantle Cell Lymphoma
Clement Bailly et al.
FRONTIERS IN MEDICINE (2019)
Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma
Pavel Klener et al.
HEMATOLOGICAL ONCOLOGY (2018)
Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma
Rustain Morgan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab
Dominick Lamonica et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC)
Federico Fallanca et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings
Myron S. Czuczman et al.
ANNALS OF HEMATOLOGY (2015)
PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis
Silvana Novelli et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
H. J. A. Adams et al.
ANNALS OF ONCOLOGY (2014)
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis
Hugo J. A. Adams et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?
Meirav Kedmi et al.
LEUKEMIA & LYMPHOMA (2014)
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma
J. B. Cohen et al.
BONE MARROW TRANSPLANTATION (2013)
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD
Anthony R. Mato et al.
CANCER (2012)
Utility of positron emission tomography scans in mantle cell lymphoma
Peter J. Hosein et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Fluorodeoxyglucose-Positron-Emission Tomography Findings in Mantle Cell Lymphoma
Abass Alavi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Increased F-18 FDG Intestinal Uptake in Diabetic Patients on Metformin A Matched Case-Control Analysis
Bohdan Bybel et al.
CLINICAL NUCLEAR MEDICINE (2011)
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group
Caroline Bodet-Milin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2010)
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome
Maroun Karam et al.
NUCLEAR MEDICINE COMMUNICATIONS (2009)
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD
Jatin J. Shah et al.
BLOOD (2008)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Positron emission tomography in mantle cell lymphoma
Lieselot Brepoels et al.
LEUKEMIA & LYMPHOMA (2008)
[18F] fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma
Saar Gill et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
High and typical F-18-FDG bowel uptake in patients treated with metformin
Eric Gontier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL):: a clinicopathological study from the European MCL Network
M Tiemann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
分享论文
